The Helen Foundation Proven Breakthrough Solution for Fibromyalgia
Our Fibromyalgia Patients Overwhelmingly Report Fast, Dramatic Symptom Relief, and have Since 1992
We offer a proven and safe treatment solution that for the overwhelming majority quickly delivers TWICE the rate of fibromylagia symptom relief as the most widely prescribed drug, without risk of harmful side effects. That's because our physician-supervised protocols and education program control against cumulative overdosing. Our Microdose Therapy solution is sustainable. You can obtain it no matter where you and your physician may be located.
We invite your inspection of the detailed information below and on other pages of this website, including the Science and FAQ pages, to learn more about our Microdose Therapy program, and why it is so effective and safe.
If you or a loved one or patient are suffering the debilitating symptoms of fibromyalgia and may be among those we can help, please call, click Free Consultations, or use the Contact Us form at the bottom of this page.
We also recommend you obtain our book, Fibromyalgia Solved (see at lower right on this page), to benefit from what Helen Foundation has learned about the role food allergies sometimes play in triggering or aggravating fibromyalgia symptoms.
Discussion: Physicians are not of one mind about fibromyalgia. In the past, many believed its symptoms were largely in the patient's mind, or were a result of a different disorder or condition. While there is yet disagreement among physicians as to the cause(s), diagnosis and treatment of fibromyalgia, there is mounting agreement that it is a painful, disabling disease and not much has been available to control it. We hasten to add "UNTIL NOW".
There are not many effective medicines for fibromyalgia. Lyrica is approved for fibromyalgia treatment, and muscle relaxants, pain relievers, and antidepressants are also prescribed. Fibromyalgia is a difficult disease.
Treating Fibromyalgia with Microdose Therapy™
Between 2000 and 2010, 545 patients with the diagnosis of fibromyalgia were enrolled into the Microdose Therapy Program. The average relief response was 77%. As they started Microdose Therapy, we allowed them to maintain the prescription medicines they were using previous to the study. The 545 patients were treated in many clinics throughout the USA. That way, one clinic couldn't prejudice the results. For Microdose Therapy to average an additional 77% relief to that being attained by standard treatments for fibromyalgia is the reason we call it a breakthrough.
Physicians reported no significant side effects in the 545-patient study. We didn't expect any. By the time we started the 545-patient study, Microdose Therapy had already been evaluated in clinical trials for rheumatoid arthritis at the University of North Dakota School of Medicine and the University of Alexandria School of Medicine during the previous 12 years. Physicians at both medical schools reported no significant side effects. Helen Foundation is seeing no significant side effects because Microdose Therapy protocols control against them while optimizing symptom relief.